These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 34938

  • 1. [Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
    Urbaszek W, Modersohn D.
    Z Arztl Fortbild (Jena); 1979 Feb 01; 73(3):101-6. PubMed ID: 34938
    [No Abstract] [Full Text] [Related]

  • 2. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH.
    Circulation; 1983 Jun 01; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [Abstract] [Full Text] [Related]

  • 3. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI, Ol'binskaia LI, Bragina GI.
    Ter Arkh; 1979 Jun 01; 51(8):13-7. PubMed ID: 41333
    [No Abstract] [Full Text] [Related]

  • 4. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E.
    MMW Munch Med Wochenschr; 1982 Apr 16; 124(15):377-80. PubMed ID: 6123078
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of adrenergic beta blockers on hemodynamics, diastolic relaxation and distensibility of left-ventricular myocardium in patients with ischemic heart disease].
    Moroz VA, Gladchenko AR, Latoguz IK, Khimenko PL.
    Klin Med (Mosk); 1991 Jan 16; 69(1):47-8. PubMed ID: 1673730
    [Abstract] [Full Text] [Related]

  • 6. [Beta receptor blockers in coronary insufficiency and acute infarct. Pathophysiological bases].
    Bleifeld W, Kupper W.
    Dtsch Med Wochenschr; 1988 Apr 08; 113(14):565-70. PubMed ID: 2895701
    [No Abstract] [Full Text] [Related]

  • 7. [The therapy of chronic heart failure with beta-receptor blockers?].
    Schwinger RH, Böhm M, Erdmann E.
    Dtsch Med Wochenschr; 1990 May 25; 115(21):825-31. PubMed ID: 1971212
    [No Abstract] [Full Text] [Related]

  • 8. Verapamil in treatment of chronic stable angina.
    Frishman WH, Charlap S.
    Arch Intern Med; 1983 Jul 25; 143(7):1407-15. PubMed ID: 6135403
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ, Raxwal VK, Roux L, Fearon WF, Froelicher VF.
    Am Heart J; 2001 Jul 25; 142(1):136-41. PubMed ID: 11431669
    [Abstract] [Full Text] [Related]

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.
    Herz; 1995 Dec 25; 20(6):399-411. PubMed ID: 8582699
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of coronary insufficiency with beta-receptor antagonists (author's transl)].
    Hitzenberger G.
    Arzneimittelforschung; 1977 Dec 25; 27(3a):700-2. PubMed ID: 17414
    [Abstract] [Full Text] [Related]

  • 12. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD, Hillis LD.
    Herz; 1982 Aug 25; 7(4):243-9. PubMed ID: 6127300
    [No Abstract] [Full Text] [Related]

  • 13. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV, Chmir VP, Krasovskaia EA, Malanchuk TA, Polishchuk II, Iashchenko OB.
    Vrach Delo; 1990 Nov 25; (11):35-8. PubMed ID: 1983050
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G.
    MMW Munch Med Wochenschr; 1975 Oct 03; 117(40):1613-4. PubMed ID: 241932
    [Abstract] [Full Text] [Related]

  • 15. [Effect of strophanthin in adrenergic blockade on the blood supply and work of the heart in acute coronary artery occlusion].
    Sapozhkov AV, Verger DIa, Vakhrameev NIa.
    Farmakol Toksikol; 1983 Oct 03; 46(1):42-5. PubMed ID: 6297963
    [Abstract] [Full Text] [Related]

  • 16. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
    Komarov FI, Ol'binskaia LI, Litvitskiĭ PF, Bragina GI.
    Farmakol Toksikol; 1982 Oct 03; 45(3):53-9. PubMed ID: 6284550
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D.
    Angiology; 1977 Dec 03; 28(12):839-43. PubMed ID: 23714
    [No Abstract] [Full Text] [Related]

  • 18. [Beta blockers in ischemic cardiopathy].
    Cía Gómez P.
    Rev Esp Cardiol; 1984 Dec 03; 37 Suppl 1():2-8. PubMed ID: 6150526
    [No Abstract] [Full Text] [Related]

  • 19. [Capillary hyperlactacidemia, criterion of exertion intolerance in patients treated with beta-blockaders].
    Haissly JC, Junod A, Curati W, Robert M, Rossel CF.
    Schweiz Med Wochenschr; 1974 Nov 02; 104(44):1592-3. PubMed ID: 4153818
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M.
    Kardiol Pol; 1982 Nov 02; 25(2):147-61. PubMed ID: 6125621
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.